$2.62
-0.08-2.96%
Pre-Market: Jul 19, 6:00 PM EDT
15 minutes delayed
Comments
Loading...
Eledon Pharma
ELDNNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Eledon Pharma (NASDAQ:ELDN) Stock, Analyst Ratings, Price Targets, Forecasts
Eledon Pharmaceuticals Inc has a consensus price target of $15.25 based on the ratings of 4 analysts. The high is $26 issued by SVB Leerink on June 1, 2022. The low is $9 issued by Cantor Fitzgerald on August 22, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 4, 2024, May 10, 2024, and May 7, 2024, respectively. With an average price target of $16 between HC Wainwright & Co., there's an implied 510.69% upside for Eledon Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Noble Capital Markets
Cantor Fitzgerald
SVB Leerink
1calculated from analyst ratings
Analyst Ratings for Eledon Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/04/2024 | Buy Now | 510.69% | HC Wainwright & Co. | Vernon Bernardino | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 510.69% | HC Wainwright & Co. | Vernon Bernardino | → $16 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 510.69% | HC Wainwright & Co. | Vernon Bernardino | $13 → $16 | Maintains | Buy | Get Alert |
| 03/22/2024 | Buy Now | 396.18% | HC Wainwright & Co. | Vernon Bernardino | → $13 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | Buy Now | 396.18% | HC Wainwright & Co. | Vernon Bernardino | → $13 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2023 | Buy Now | 396.18% | HC Wainwright & Co. | Vernon Bernardino | $25 → $13 | Maintains | Buy | Get Alert |
| 09/27/2023 | Buy Now | 281.68% | Noble Capital Markets | Robert LeBoyer | → $10 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | Buy Now | 243.51% | Cantor Fitzgerald | Alethia Young | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | Buy Now | 854.2% | HC Wainwright & Co. | Vernon Bernardino | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2022 | Buy Now | 892.37% | SVB Leerink | Thomas Smith | $33 → $26 | Maintains | Outperform | Get Alert |
| 11/24/2021 | Buy Now | 854.2% | HC Wainwright & Co. | Vernon Bernardino | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Eledon Pharma (ELDN) stock?
The latest price target for Eledon Pharma (NASDAQ:ELDN) was reported by HC Wainwright & Co. on June 4, 2024. The analyst firm set a price target for $16.00 expecting ELDN to rise to within 12 months (a possible 510.69% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eledon Pharma (ELDN)?
The latest analyst rating for Eledon Pharma (NASDAQ:ELDN) was provided by HC Wainwright & Co., and Eledon Pharma reiterated their buy rating.
When was the last upgrade for Eledon Pharma (ELDN)?
There is no last upgrade for Eledon Pharma
When was the last downgrade for Eledon Pharma (ELDN)?
There is no last downgrade for Eledon Pharma.
When is the next analyst rating going to be posted or updated for Eledon Pharma (ELDN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eledon Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eledon Pharma was filed on June 4, 2024 so you should expect the next rating to be made available sometime around June 4, 2025.
Is the Analyst Rating Eledon Pharma (ELDN) correct?
While ratings are subjective and will change, the latest Eledon Pharma (ELDN) rating was a reiterated with a price target of $16.00 to $16.00. The current price Eledon Pharma (ELDN) is trading at is $2.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.